Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conference:
- Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the 33rd Annual Piper Sandler Virtual Healthcare Conference on Wednesday, December 1, 2021 at 2:30 PM (ET). The presentation will be concurrently webcast.
The link to the webcast will be available on the Dexcom IR website at investors.dexcom.com by navigating to “Events and Presentations.”
About DexCom, Inc.
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211129005069/en/
Dexcom Inc. Aktie
Deutliche Kaufsignale für Dexcom Inc. mit mehreren Buy- und keinen Sell-Einschätzungen.
Mit einem Kursziel von 136 € für Dexcom Inc. könnte eine leichte Steigerung gegenüber dem aktuellen Kurs von 119.84 € erreicht werden.
